SCHEMBL1630236

SCHEMBL1630236

CCN(CC)S(=O)(=O)c1cc(-c2ccnn2-c2ccccc2Cl)c(OC)cc1OC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
MAPT P10636 1/20 0.41
TSHR P16473 5/20 0.41
KDM4E B2RXH2 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
HSP90AA1 P07900 1/20 0.39
POLB P06746 1/20 0.38
PI4KB Q9UBF8 1/20 0.38
CYP1A2 P05177 2/20 0.38
TP53 P04637 1/20 0.38
CYP3A4 P08684 1/20 0.38
GAA P10253 1/20 0.38
CYP2C9 P11712 1/20 0.38
PDE11A Q9HCR9 1/20 0.37
SLC16A3 O15427 2/20 0.36
SLC16A1 P53985 2/20 0.36
CYP2C19 P33261 1/20 0.36
MCOLN3 Q8TDD5 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1630004 0.91 HSP90AA1 (0.38) ALDH1A1MAPTTSHRHSP90AA1PDE11A
SCHEMBL1631535 0.89 TSHR (0.46) ALDH1A1TSHRKDM4ESMN1; SMN2MEN1
SCHEMBL1631566 0.89 TSHR (0.44) ALDH1A1MAPTTSHRSMN1; SMN2HSP90AA1
SCHEMBL1631603 0.88 HSP90AA1 (0.37) ALDH1A1MAPTTSHRMEN1KMT2A
SCHEMBL1629889 0.87 HSP90AA1 (0.43) ALDH1A1MAPTTSHRSMN1; SMN2HSP90AA1
SCHEMBL1630393 0.86 HSP90AA1 (0.38) MAPTTSHRMEN1KMT2AHSP90AA1
SCHEMBL1216917 0.86 MAPT (0.44) ALDH1A1MAPTKDM4ESMN1; SMN2MEN1
SCHEMBL1219165 0.86 HSP90AA1 (0.40) ALDH1A1MAPTTSHRSMN1; SMN2HSP90AA1
SCHEMBL1629173 0.85 HSP90AA1 (0.38) ALDH1A1TSHRKDM4EHSP90AA1CYP3A4
SCHEMBL1630418 0.85 HSP90AA1 (0.41) ALDH1A1MAPTTSHRSMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P ALDH1A1 777/4885MAPT 2299/4885TSHR 1658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.